April 18, 2019
FDA continues efforts to assess duodenoscope contamination risk
Editor's Note
The Food & Drug Administration (FDA) on April 12 announced that it is taking steps to implement additional regulatory actions, including consulting with federal health experts, on how to reduce the risks of contamination and infections linked to duodenoscopes.
The agency is also collaborating with manufacturers of disposable duodenoscopes that would make reprocessing unnecessary, and they are collaborating on new duodenoscope designs that may lower contamination risks.
Free Daily News
- Study: Predictive model improves nosocomial infection risk assessment after colon cancer surgery
- New colonoscopy guidelines increase bowel prep quality expectations
- Healthcare employment up in February
- New legal standard redefines medical negligence
- Study: Machine learning improves OR efficiency, but challenges remain
- Study: Weekend effect raises risk of surgical patient mortality, complications
- 4-day workweek boosts job satisfaction, work-life balance for nurse leaders
- Open-heart surgery performed on infant mid-delivery
- Infusion pumps deemed high-risk in FDA early alert
- Stem cell researchers tout potential for sickle cell disease cure
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement